AAAAAA

   
Results: 1-8 |
Results: 8
High-dose chemotherapy with peripheral blood stem cell transplantation forpatients with advanced ovarian cancer
Authors: Bojko, P Scheulen, ME Hilger, R Oberhoff, C Schindler, AD Seeber, S
Citation: P. Bojko et al., High-dose chemotherapy with peripheral blood stem cell transplantation forpatients with advanced ovarian cancer, J CANC RES, 127(4), 2001, pp. 243-250
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies
Authors: Scheulen, ME Hilger, RA Oberhoff, C Casper, J F'reund, M Josten, KM Bornhauser, M Ehninger, G Berdel, WE Baumgart, J Harstrick, A Bojko, P Wolf, HH Schindler, AE Seeber, S
Citation: Me. Scheulen et al., Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies, CLIN CANC R, 6(11), 2000, pp. 4209-4216
Simultaneous measurement of cellular P-glycoprotein content and function by multiparametric flow-cytometry
Authors: Muller, MR Lennartz, K Baack, B Heim, MME Seeber, S Scheulen, ME
Citation: Mr. Muller et al., Simultaneous measurement of cellular P-glycoprotein content and function by multiparametric flow-cytometry, INT J CL PH, 38(4), 2000, pp. 180-186
Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia
Authors: Flasshove, M Meusers, P Schutte, J Noppeney, R Beelen, DW Sohrab, S Roggenbuck, U Kemmeries, G Brittinger, G Seeber, S Scheulen, ME
Citation: M. Flasshove et al., Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia, ANN HEMATOL, 79(10), 2000, pp. 533-542
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer
Authors: Hilger, RA Jacek, G Oberhoff, C Kredtke, S Baumgart, J Seeber, S Scheulen, ME
Citation: Ra. Hilger et al., Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer, CANC CHEMOT, 45(6), 2000, pp. 483-488
In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia
Authors: Schroder, JK Kasimir-Bauer, S Seeber, S Scheulen, ME
Citation: Jk. Schroder et al., In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia, J CANC RES, 126(2), 2000, pp. 111-116
Phase II study with interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell carcinoma - A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society
Authors: Mross, K Scheulen, ME Manegold, C Westerhausen, M Edler, L Becher, R
Citation: K. Mross et al., Phase II study with interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell carcinoma - A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society, ONKOLOGIE, 22(5), 1999, pp. 412-415
Expression of heat shock proteins 27 and 70 in renal cell cancer and normal renal tissue: An immunohistochemical study
Authors: Bex, A Geis, C Metz, K Kasimir-Bauer, S Scheulen, ME Otto, T Rubben, H
Citation: A. Bex et al., Expression of heat shock proteins 27 and 70 in renal cell cancer and normal renal tissue: An immunohistochemical study, ONKOLOGIE, 22(3), 1999, pp. 236-239
Risultati: 1-8 |